Mesenchymal stem cell therapy in lung disorders: Pathogenesis of lung diseases and mechanism of action of mesenchymal stem cell

@article{Inamdar2013MesenchymalSC,
  title={Mesenchymal stem cell therapy in lung disorders: Pathogenesis of lung diseases and mechanism of action of mesenchymal stem cell},
  author={Ajinkya C. Inamdar and Arati A Inamdar},
  journal={Experimental Lung Research},
  year={2013},
  volume={39},
  pages={315 - 327}
}
ABSTRACT Lung disorders such as asthma, acute respiratory distress syndrome (ARDS), chronic obstructive lung disease (COPD), and interstitial lung disease (ILD) show a few common threads of pathogenic mechanisms: inflammation, aberrant immune activity, infection, and fibrosis. Currently no modes of effective treatment are available for ILD or emphysema. Being anti-inflammatory, immunomodulatory, and regenerative in nature, the administration of mesenchymal stem cells (MSCs) has shown the… Expand

Paper Mentions

Interventional Clinical Trial
Pulmonary Disorders are often categorized as Obstructive or Restrictive disorders. This study will establish two channels of investigation, one group within each type of pulmonary… Expand
ConditionsCOPD, Respiratory Insufficiency
InterventionProcedure
Interventional Clinical Trial
Chronic Obstructive Pulmonary Disease (COPD) is a lung-related disorder that is characterized by long-term, often progressive state of poor airflow. Primary symptoms include low oxygen… Expand
ConditionsLung Disease
InterventionProcedure
Interventional Clinical Trial
This study is being done to test if it is safe to give stem cells to adult patients with Cystic Fibrosis (CF). The kind of stem cells we are studying are called allogeneic human… Expand
ConditionsCystic Fibrosis
InterventionBiological
Mesenchymal Stem Cell-Based Therapy of Inflammatory Lung Diseases: Current Understanding and Future Perspectives
TLDR
Molecular mechanisms involved in MSC-based therapy of acute and chronic pulmonary diseases and current knowledge and future perspectives related to the therapeutic application of MSCs in patients suffering from acute respiratory distress syndrome, pneumonia, asthma, chronic obstructive pulmonary diseases, and idiopathic pulmonary fibrosis are described. Expand
Stem cell therapy in chronic obstructive pulmonary disease. How far is it to the clinic?
TLDR
The current evidence of stem cell therapy in COPD is reviewed and it is suggested that cell-based therapies and novel bioengineering approaches may be potential therapeutic strategies for lung repair and remodelling. Expand
A narrative review of research advances in mesenchymal stem cell therapy for asthma.
TLDR
MSCs exert their therapeutic effects on asthma by restoring Th1/Th2 balance, reversing Th17/Tregs imbalance, inhibiting DC maturation, and promoting the switch of M1 to M2 and repairing epithelial injury, suggesting that MSCs may be a promising treatment for asthma. Expand
Mesenchymal stem cells suppress lung inflammation and airway remodeling in chronic asthma rat model via PI 3 K / Akt signaling pathway
Background: Mesenchymal stem cells (MSCs) came out to attract wide attention and had become one of the hotspots of most diseases’ research in decades. But at present, the mechanisms of how MSCs workExpand
Can Youthful Mesenchymal Stem Cells from Wharton’s Jelly Bring a Breath of Fresh Air for COPD?
TLDR
The present review discusses the main biological properties of WJ-MSCs pertinent to their potential application for the treatment of COPD in the context of COPDs pathomechanisms with emphasis on chronic immune inflammatory processes that play key roles in the development and progression of COPd. Expand
The long and winding road: stem cells for cystic fibrosis
TLDR
The clinical application of stem cells for the treatment of CF certainly warrants further insight into pre-clinical models, including large animals, organoids, decellularized organs and lung bioengineering. Expand
Therapeutic Effects of Human Umbilical Cord-Derived Mesenchymal Stem Cells in Acute Lung Injury Mice
TLDR
It is found that intratracheal administration of human umbilical cord-mesenchymal stem cells (UC-MSCs) significantly improved survival and attenuated the lung inflammation in lipopolysaccharide (LPS)-induced ALI mice. Expand
The clinical use of regenerative therapy in COPD
TLDR
Current evidence suggests that in the lung, bone marrow-derived stem cells may participate in tissue homeostasis and regeneration after injury, and thus administration of exogenous stem/progenitor cells or humoral factors responsible for the activation of endogenous stem/ ProGenitor cells may be a potent next-generation therapy for chronic obstructive pulmonary disease. Expand
Mesenchymal Stem Cells Suppress Severe Asthma by Directly Regulating Th2 Cells and Type 2 Innate Lymphoid Cells
  • Jae Woo Shin, Seungwon Ryu, +5 authors Hye Young Kim
  • Medicine
  • Molecules and cells
  • 2021
TLDR
Results showed that hUC-MSC treatment can ameliorate asthma by suppressing the asthmogenic cytokine production of effector cells, however, the successful clinical application of MSCs in the future is likely to require careful optimization of the route, dosage, and timing. Expand
Hypoxia-preconditioned mesenchymal stem cells attenuate bleomycin-induced pulmonary fibrosis
TLDR
Transplantation of hypoxia-preconditioned MSCs exerted better therapeutic effects in bleomycin-induced pulmonary fibrotic mice and enhanced the survival rate of engrafted MSCS, partially due to the upregulation of hepatocyte growth factor. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 132 REFERENCES
Mesenchymal stem cells protect cigarette smoke‐damaged lung and pulmonary function partly via VEGF–VEGF receptors
TLDR
It is suggested that MSCs have a therapeutic potential in emphysematous rats by suppressing the inflammatory response, excessive protease expression, and cell apoptosis, as well as up‐regulating VEGF, V EGF receptor 2, and TGFβ‐1. Expand
Cellular therapies for lung disease: A distant horizon
TLDR
There are clinical trials underway to examine the potential for cellular therapies in lung disease from a variety of cell examined for both their immunomodulatory effects on the lung as well as their potential for differentiation into lung cells. Expand
Human mesenchymal stem cells suppress chronic airway inflammation in the murine ovalbumin asthma model.
TLDR
The studies show the effectiveness and specificity of the hMSCs on decreasing chronic airway inflammation associated with the murine ovalbumin model of asthma and verify the in vivo immunoeffectiveness of hMSC in rodents and support the potential therapeutic use of h MSCs for the treatment of airwayinflammation associated with chronic asthma. Expand
A placebo-controlled, randomized trial of mesenchymal stem cells in COPD.
TLDR
Systemic MSC administration appears to be safe in patients with moderate to severe COPD and provides a basis for subsequent cell therapy investigations. Expand
Mesenchymal Stem Cell Transfer Suppresses Airway Remodeling in a Toluene Diisocyanate-Induced Murine Asthma Model
TLDR
The systemic transfer of BMDMSCs effectively reduced experimental TDI-induced airway inflammation and remodeling and airway hyperreactivity in a TDI-induced asthma animal model of severe asthma. Expand
Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury.
TLDR
The results of this study suggest that uMSCs have antifibrotic properties and may augment lung repair if used to treat acute respiratory distress syndrome. Expand
Adult mesenchymal stem cells: an innovative therapeutic for lung diseases.
TLDR
Current concepts of human mesenchymal stem cells functions with a focus on the clinical utility of hMSCs in the treatment of lung diseases are highlighted. Expand
Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury
TLDR
MSCs protect lung tissue from BLM-induced injury by blocking TNF-α and IL-1, two fundamental proinflammatory cytokines in lung, which may provide a novel cellular vector for treating chronic inflammatory diseases in humans. Expand
Exosomes Mediate the Cytoprotective Action of Mesenchymal Stromal Cells on Hypoxia-Induced Pulmonary Hypertension
TLDR
This study indicates that MEX exert a pleiotropic protective effect on the lung and inhibit pulmonary hypertension through suppression of hyperproliferative pathways, including STAT3-mediated signaling induced by hypoxia. Expand
Bone marrow cells repair cigarette smoke-induced emphysema in rats.
TLDR
The repair activity of these treatments is consistent with a paracrine effect rather than stem cell engraftment because most of the donor cells disappeared and because cell-free MSC-CM also induced the repair. Expand
...
1
2
3
4
5
...